Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

EVIDENCEB : revenue, balance sheet and financial ratios

EVIDENCEB is a French company founded 8 years ago, specialized in the sector Programmation informatique. Based in PARIS (75018), this company of category PME shows in 2024 a net income positive of 204 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EVIDENCEB (SIREN 831042148)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 204 291 € -1 602 346 € -667 292 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, EVIDENCEB generates positive net income of 204 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

204 291 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 161%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

160.549%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.225%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

25.8%

Solvency indicators evolution
EVIDENCEB

Sector positioning

Debt ratio
160.55 2024
2022
2023
2024
Q1: 0.0
Med: 3.36
Q3: 42.51
Average

In 2024, the debt ratio of EVIDENCEB (160.55) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.23% 2024
2022
2023
2024
Q1: 3.88%
Med: 34.74%
Q3: 63.98%
Average -23 pts over 3 years

In 2024, the financial autonomy of EVIDENCEB (31.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 103.06. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

103.057

Liquidity indicators evolution
EVIDENCEB

Sector positioning

Liquidity ratio
103.06 2024
2022
2023
2024
Q1: 132.21
Med: 250.32
Q3: 499.26
Average -45 pts over 3 years

In 2024, the liquidity ratio of EVIDENCEB (103.06) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of EVIDENCEB in its sector

Comparison with sector Programmation informatique

Valuation estimate

Based on 120 transactions of similar company sales (all years), the value of EVIDENCEB is estimated at 439 729 € (range 190 816€ - 1 214 425€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
120 transactions
190k€ 439k€ 1214k€
439 729 € Range: 190 816€ - 1 214 425€
NAF 5 all-time

Valuation method used

Net Income Multiple
204 291 € × 2.2x = 439 730 €
Range: 190 816€ - 1 214 426€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 120 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Programmation informatique)

Compare EVIDENCEB with other companies in the same sector:

Frequently asked questions about EVIDENCEB

What is the revenue of EVIDENCEB ?

The revenue of EVIDENCEB is not publicly disclosed (confidential accounts filed with INPI).

Is EVIDENCEB profitable?

Yes, EVIDENCEB generated a net profit of 204 k€ in 2024.

Where is the headquarters of EVIDENCEB ?

The headquarters of EVIDENCEB is located in PARIS (75018), in the department Paris.

Where to find the tax return of EVIDENCEB ?

The tax return of EVIDENCEB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EVIDENCEB operate?

EVIDENCEB operates in the sector Programmation informatique (NAF code 62.01Z). See the 'Sector positioning' section above to compare the company with its competitors.